The discovery of the important role of the adenosine-A2AR pathway in the human body [not only in cancer but also in other diseases such as Parkinson’s disease (67, 68)], has made the development of effective and selective A2A adenosine receptor antagonists an appealing research field. This evidence concerns the gene ADORA2A and cancer.